CLINICAL_TRIALS
trial_result
· 2012-11-09
Clinical Trial Update: Study In Patients With Kidney Cancer Treated With Sutent
Summary
A completed clinical trial evaluated Sutent (sunitinib) in patients with advanced or metastatic renal cell carcinoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Advanced or Metastatic Renal Cell Carcinoma, Renal Cancer | Status: COMPLETED